"TAP não sobrevive se se mantiver pública", garante Pinto Luz

[agany]

Lactobacillus acidophilus - cápsulas para repor a flora vaginal.

[Marco Martins]

...resta agora saber quantas empresas mais vão cair atrás desta...

[Sr_SNiper]

Ainda se vai a tempo de shortar? esse volume nesse suporte...

[Luka!]

Neste caso sobre a empresa China Biotics :

Citron Research is out with a very negative report on shares of China-Biotics Inc. (NASDAQ: CHBT), essentially calling the company a fraud.

In the report, Citron writes, "It would be easy to look at the gross discrepancies between the company’s SAIC and SEC filings. It would also be possible to show pictures of the half-finished over-budget manufacturing facility side-by-side with company claims that it was already in production, or the photos of their current production facilities the size of a “bathroom” where the acidophilus pills drop out of a machine two by two. Most compelling, it would be simple to question how a company who sells the bulk of their product though distributors, who then purportedly resell them to Wal Mart (so they claim) can generate EBIDTA margins of 40-45% when their competition is at 27% max. (Multinational companies in the business include Danisco, Yakult, Perrigo, Cargill and others.)"

To read more from the research report, visit the report in its entirety here.

Shares of CHBT are plummeting on this report, losing 7.5% to trade at $13.58.

AQUI TEM MAIS DETALHES
COMO AS ENTRADAS E SAIDAS DE DIRECTORES FINANCEIROS
... impressionante !
http://citronresearch.com/




http://www.benzinga.com/analyst-ratings ... search-chb